In an intriguing study by Nguyen et al., next-generation sequencing and CRISPR-Cas9 screens identified mutations in the interferon-JAK-STAT signaling pathway in melanoma cells as associated with resistance to anti-PD-1 therapy (Nguyen et al., 2021). This evidence concerns the gene PDCD1 and melanoma.